STOCK TITAN

Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Science 37 Holdings, Inc. (Nasdaq: SNCE) will report Q3 2023 financial results on November 7, 2023. A conference call will be held at 8:30 a.m. ET to discuss the results. The webcast can be accessed on the company's website.
Positive
  • Science 37 Holdings, Inc. will report Q3 2023 financial results on November 7, 2023, potentially providing insights into the company's performance and future prospects.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™ today announced it will report third quarter 2023 financial results prior to the market open on Tuesday, November 7, 2023.

The Science 37 management team will host a conference call to discuss these results on November 7, 2023, at 8:30 a.m. Eastern Time. The call can be accessed by dialing 1-877-269-7751 (toll-free domestic) or 1-201-389-0908 (international) and using the Conference ID 13741458 or by utilizing the Call me™ feature using this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Science 37 website. A replay of the webcast will be available for approximately 90 days.

About Science 37

Science 37 Holdings, Inc.’s (Nasdaq: SNCE) mission is to accelerate clinical research by enabling universal trial access for patients. Through our Metasite™ we reach an expanded population beyond the traditional site, delivering on our goal of clinical research that works for everyone—with greater patient diversity. Patients gain the flexibility to participate from the comfort of their own homes, at their local community provider, or at a traditional site when needed. Our Metasite is powered by a proprietary technology platform with in-house medical and operational experts that drive uniform study orchestration, enabling greater compliance and high-quality data. To learn more, visit www.science37.com, or email science37@science37.com.

Contacts:

MEDIA INQUIRIES:
Grazia Mohren
Science 37
Email: pr@science37.com

INVESTOR RELATIONS:
Steve Halper
LifeSci Advisors
Email: shalper@lifesciadvisors.com


FAQ

When will Science 37 Holdings, Inc. report its Q3 2023 financial results?

Science 37 Holdings, Inc. will report its Q3 2023 financial results on November 7, 2023.

What time is the conference call to discuss the Q3 2023 financial results?

The conference call to discuss the Q3 2023 financial results will be held at 8:30 a.m. Eastern Time.

How can I access the webcast of the conference call?

The webcast can be accessed via the investor relations section of the Science 37 website.

Will there be a replay of the webcast available?

Yes, a replay of the webcast will be available for approximately 90 days.

Science 37 Holdings, Inc.

NASDAQ:SNCE

SNCE Rankings

SNCE Latest News

SNCE Stock Data

34.66M
4.13M
16.89%
52.18%
0.23%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States
Research Triangle Park

About SNCE

science 37 uses advanced telemedicine technology and patient-centric innovative networked clinical research models to rapidly accelerate biomedical discovery and bring down the costs of clinical trials. in addition to our own researchers, we also work closely with top physician-scientists and leading telemedicine companies. s37 offers full support and end-to-end services for networked clinical trials. if you are an investigator, an inventor, a small biotech company or a large pharmaceutical company, we can help you achieve your clinical trial goals faster and easier than ever before. based in los angeles, we are focused on the development of networked patient-centric models for clinical research to rapidly accelerate biomedical discovery. we leverage partnerships with national mobile nursing companies, pharmacy chains, patient advocacy groups, virtual e-consenting, mobile devices, and other technology companies to maximize efficiency. then, using design-thinking principles and rapid pr